financetom
Business
financetom
/
Business
/
Sun Life US dental business has quarterly loss but on track to earn $100 mln in 2025
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Sun Life US dental business has quarterly loss but on track to earn $100 mln in 2025
Aug 13, 2024 10:46 AM

TORONTO, Aug 13 (Reuters) - Sun Life Financial Inc ( SLF )

CEO Kevin Strain said on Tuesday the company's U.S.

dental insurance business was improving after losing money in

the latest quarter, and was on track to hit its goal for $100

million in earnings in that segment in 2025.

The Canadian insurer's shares were up about 5% in mid-day

trading in Toronto after its second quarter earnings topped

expectations.

The dental segment posted a loss for the second quarter hit

by Medicaid redeterminations that pressure Medicaid and Medicare

Advantage sales leading to a 5% fall in the US segment's core

earnings.

As more Medicaid contracts are repriced along with broader

expense reductions, the segment is expected to see improvements.

About 90% of Medicaid contracts are expected to be repriced

this year, the company said.

"We still think that the U.S. is a good long term growth

market for us in both the group benefit side (and) in the asset

management side under both MFS and SLC," Strain said in an

interview.

Sun Life acquired dental benefits provider DentaQuest as

part of its strategy to grow its presence in the U.S., which now

accounts for roughly a fifth of its overall undelying income.

"We would look at expanding growth there (U.S.), as well as

in Asia," he said, adding that US is a growing segment with

potential in both insurance and asset management.

Jefferies analyst John Aiken noted that while the U.S.

dental business faced challenges, it provides "upside potential

that should be easily recognized with the management actions

taken to date."

Sun Life's Tuesday gains took its year-to-date performance

to positive territory. Rival Manulife's shares have

gained 18.8% so far this year.

(Reporting by Nivedita Balu in Toronto)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Venezuela's oil exports fall over lower inventories, imports
Venezuela's oil exports fall over lower inventories, imports
Nov 3, 2025
* Venezuela's oil exports drop 26% from September * Imports of diluents from Russia decreased significantly * China remains primary destination for Venezuelan oil exports By Marianna Parraga HOUSTON, Nov 3 (Reuters) - Venezuela's oil exports declined 26% to some 808,000 barrels per day in October as the country's stocks dwindled and it imported smaller volumes of diluents to produce...
Novo Nordisk says Metsera bid won't raise antitrust issues
Novo Nordisk says Metsera bid won't raise antitrust issues
Nov 3, 2025
COPENHAGEN (Reuters) -Denmark's Novo Nordisk said on Monday it is confident that its proposed takeover of U.S. drugmaker Metsera ( MTSR ) does not raise any antitrust issues. Novo Nordisk last week launched a rival bid for obesity biotech Metsera ( MTSR ), exceeding an offer from Pfizer ( PFE ) as the drugmakers jostled for advantage in the highly...
FMC Earnings Expected to Miss Estimates Amid Falling Volume, Pricing Pressure, Morgan Stanley Says
FMC Earnings Expected to Miss Estimates Amid Falling Volume, Pricing Pressure, Morgan Stanley Says
Nov 3, 2025
12:07 PM EST, 11/03/2025 (MT Newswires) -- FMC's (FMC) earnings are expected to fall below estimates due to falling volumes and pricing challenges in parts of the company's portfolio, Morgan Stanley said in a note Monday. Morgan Stanley said FMC needs to show earnings before interest, taxes, depreciation, and amortization resilience in both its legacy and diamide businesses by 2026...
Cloud startup Lambda unveils multi-billion-dollar deal with Microsoft
Cloud startup Lambda unveils multi-billion-dollar deal with Microsoft
Nov 3, 2025
Nov 3 (Reuters) - Artificial intelligence cloud startup Lambda said on Monday it has entered into a multi-billion-dollar agreement with Microsoft ( MSFT ) to deploy tens of thousands of AI chip leader Nvidia's ( NVDA ) graphics processors. Lambda did not provide further details on a specific deal value or timeline for the deployment in its statement. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved